New dissolving paracetamol tablet put to the test
NCT ID NCT06855576
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study tests whether a new paracetamol tablet that dissolves in the mouth (orodispersible) works the same as two existing paracetamol tablets. Healthy adults aged 18 to 55 take a single dose of each tablet on separate days, and researchers measure how much paracetamol gets into the blood. The goal is to see if the new tablet is a suitable alternative for people who have trouble swallowing pills.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Paracetamol
What this could lead to
If successful, this could provide a new, easier-to-take form of paracetamol that dissolves in the mouth.
What could go wrong
This is an early-phase study in healthy volunteers, so results may not apply to people with pain or fever. The new tablet may not be absorbed identically.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SocraTec R&D GmbH
Erfurt, Thuringia, 99084, Germany